The Use of Natalizumab (Tysabri) for the Treatment of Multiple Sclerosis
Guideline, September 2008
Read Published ArticleRetired guideline.
Questions?
Email guidelines@aan.com
Call (800) 879-1960 or (612) 928-6000 (international)
Retired guideline.
Email guidelines@aan.com
Call (800) 879-1960 or (612) 928-6000 (international)